What is the appropriate telehealth approach to assess a rash in a patient on methadone, including required history, photograph guidelines, and red‑flag criteria for urgent in‑person evaluation?

Telehealth Assessment of Rash in Patients on Methadone

For patients on methadone presenting with a rash via telehealth, immediately assess for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) red flags, obtain high-quality photographs of all affected areas including mucous membranes, and arrange urgent in-person evaluation if any concerning features are present.

Critical History Elements

When assessing a rash in a methadone patient via telehealth, obtain the following specific information 1:

Drug-Related History

• Exact date the rash first appeared and progression timeline
• All medications taken in the previous 2 months, including:
  • Methadone dose and any recent changes
  • Over-the-counter medications
  • Complementary/alternative therapies
  • Date each medication was started
  • Any brand switches or medication errors
• Previous drug allergies with specific reaction details

Symptom Assessment

• Prodromal symptoms: fever, malaise, upper respiratory symptoms, sore throat
• Skin pain (a critical warning sign for SJS/TEN)
• Mucosal involvement: sore eyes, mouth, nose, or genitalia
• Respiratory symptoms: cough, shortness of breath, bloody sputum
• Gastrointestinal symptoms: diarrhea, abdominal distension

Medical Context

• History of recurrent herpes simplex virus infections
• History of chest infections
• Current medical problems

Photograph Guidelines

Direct the patient to capture 2, 3:

Required Images

1. Full body overview in good lighting
2. Close-up photographs of affected areas showing:
   • Individual lesions with a ruler or coin for scale
   • Distribution pattern
3. All mucosal surfaces:
   • Inside of mouth (pull cheeks aside)
   • Eyes (open and closed views)
   • Genital area if involved
4. Palms and soles (often missed but diagnostically important)

Photography Instructions

• Use natural lighting or bright indoor light
• Take photos perpendicular to skin surface
• Include reference object for size
• Capture both wide-angle and close-up views
• Photograph unaffected skin for comparison

Red-Flag Criteria for Urgent In-Person Evaluation

Arrange immediate in-person assessment if ANY of the following are present 1:

High-Risk Features (SJS/TEN)

• Skin pain preceding or accompanying rash
• Target lesions (especially atypical targets)
• Purpuric macules (non-blanching purple spots)
• Blisters or epidermal detachment
• Mucosal involvement (eyes, mouth, nose, genitalia)
• Facial or chest predominance with rapid spread

Systemic Warning Signs

• Fever with rash
• Respiratory symptoms: cough, dyspnea, hemoptysis
• Eye symptoms: purulent discharge, eyelid swelling, visual changes
• Oral lesions: painful erosions, difficulty swallowing

Timing Concerns

• Rash onset within 8 weeks of starting methadone or any new medication 1
• Rapid progression over hours to days

Common Pitfalls to Avoid

Methadone-Specific Considerations

While methadone can cause various adverse reactions 4, including skin manifestations, do not dismiss a rash as a minor side effect without proper evaluation. Methadone patients may have:

• Multiple concurrent medications increasing drug reaction risk
• Delayed presentation due to access barriers
• Concurrent infections (hepatitis, HIV) affecting skin manifestations

Telehealth Limitations

• Cannot perform physical touch assessment for skin texture, warmth, or Nikolsky sign (epidermal detachment with gentle pressure) 2
• Difficult to assess true body surface area involvement without in-person examination
• Color accuracy varies with lighting and camera quality
• Cannot perform full body examination as thoroughly as in-person

When Telehealth is Insufficient

Immediately refer for in-person evaluation rather than continuing telehealth assessment if 1:

• Any SJS/TEN features are suspected
• Unable to adequately visualize mucosal surfaces
• Patient reports skin pain or systemic symptoms
• Rapid progression is described
• Blistering or skin detachment visible in photos

Documentation Requirements

Record 1:

• Date of rash onset (index date)
• Baseline vital signs if patient can measure (temperature, pulse, oxygen saturation if available)
• All current medications with start dates
• Quality assessment of photographs received
• Clinical decision-making rationale
• Clear follow-up plan with specific timeframe

The threshold for in-person evaluation should be low in methadone patients given the potential for serious drug reactions and the limitations of remote assessment.